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Dear Editor,
The ubiquitin speciﬁc protease 7 (USP7), also known as
herpes virus associated ubiquitin speciﬁc protease
(HAUSP), is a well-characterized deubiquitinase (Reyes-
Turcu et al., 2009). USP7 plays important roles in various
biological processes, including cell survival, proliferation,
apoptosis, tumorigenesis, viral infection, and epigenetic
regulation through regulating the protein stability of tumor
suppressors (p53, PTEN, FOXO, claspin), E3 ligases
(MDM2, Mule, viral proteins ICP0), epigenetic regulators
(DNMT1, Tip60, UHRF1) (Pfoh et al., 2015). USP7 is com-
prised of three recognizable domains: the N-terminal TRAF
domain, the catalytic domain, and the C-terminal Tandem
UBL domain (designated TUDUSP7) (Fig. 1A). Previous study
shows that the TRAF domain binds to P/AxxS motif (from
p53 and MDM2) and is responsible for substrate recognition
(Sheng et al., 2006). However, how USP7 recognizes other
substrates remains largely unknown.
Previous study shows that TUDUSP7 is important for the
regulation of USP7 enzymatic activity (Faesen et al., 2011).
We have previously showed that USP7 stabilizes UHRF1
through the interaction between TUDUSP7 and a Spacer
region between the SRA and RING domain of UHRF1 (Ma
et al., 2012). Our recent study indicates that USP7 binds to
and stabilizes DNMT1 through the interaction between an
acidic pocket of TUDUSP7 and the KG repeat region (KG-
Linker) of DNMT1. We therefore speculate that TUDUSP7
may function as a binding site for some other USP7-binding
proteins or substrates. To test this hypothesis, we ﬁrst
investigated the interaction between USP7 and the Herpes
simplex virus type 1 (HSV1) regulatory protein ICP0 (also
known as Vmw110), which is the ﬁrst identiﬁed USP7-inter-
acting protein and regulates the lytic and latent viral infection
through inducing proteasomal degradation of various cellular
proteins (Boutell and Everett, 2013).
It has been shown that ICP0 peptide (residues 594–633)
interacts with the TUD of USP7 (Everett et al., 1999). To
investigate how ICP0 binds to TUDUSP7, we determined the
crystal structure of TUDUSP7 in complex with ICP0 (613–633)
at 2.70 Å resolution (Fig. 1A, Table S1). In the TUDUSP7-ICP0
complex structure, the TUDUSP7 adopts an extended confor-
mation, and shares similar fold with the TUDUSP7 alone
(2YLM.PDB) (Faesen et al., 2011) (Fig. S1). As observed in
previous studies (Faesen et al., 2011; Cheng et al., 2015),
UBL1–2, UBL3, and UBL4–5 of TUDUSP7 form three separate
modules and are connected by ﬂexible regions ﬂanking the
UBL3.The ICP0packsagainst anacidic grooveon thesurface
of UBL1–2. Most of the residues involved in intermolecular
interaction are well covered by the electron density, indicating
the model was correctly built (Fig. S2).
As indicated in the TUDUSP7-ICP0 structure, the interaction
is mediated by a network of hydrogen bonds and salt bridge
contacts. Residue K620ICP0 forms hydrogen bonds with the
carbonyl oxygen atoms of residues K681USP7, D684USP7 and
side chain of D762USP7. Residue K624ICP0 snugly inserts into
an acidic cavity, with the side chain stabilized by residues
E759USP7 and D764USP7. Hydroxyl group of T625ICP0 forms
hydrogen bond with E759USP7. Residues R626ICP0 and
H627ICP0 form hydrogen bonds with side chain of residue
D758USP7. The carboxyl group of residue E629 interacts with
the side chain of K739USP7. Themain chains of ICP0 (residues
C621, T625, and R626) form hydrogen bonds with residue
K739USP7, L760USP7, andE759USP7 (Fig. 1B). Consistent with
the observation from the structural analyses, mutations
K624AICP0 (1KA) and K620A/K624AICP0 (2KA) of ICP0, lar-
gely decreased the binding afﬁnities to TUDUSP7, compared
with the wild-type ICP0 (Fig. 1C), supporting the key role of
these residues in mediating the intermolecular interaction.
Our previous study indicates that the KG-Linker of
DNMT1 binds to TUDUSP7 and plays an important role in
mediating DNMT1-USP7 interaction and USP7-mediated
stabilization of DNMT1. Structural comparison of USP7-
DNMT1 and USP7-ICP0 indicates that ICP0 and KG-Lin-
kerDNMT1 pack against the same acidic pocket of TUDUSP7 in
an opposite orientation (Cheng et al., 2015). As shown in
Fig. 1D, residues K624ICP0 and K1111DNMT1 both bind to the
acidic cavity formed by residues E736USP7, D758USP7,
E759USP7, and D764USP7, and residues K620ICP0 and
K1115DNMT1 form hydrogen bonds with D684USP7 and
D762USP7. In support of above observation, mutation D758A/
E759A/E764A of TUDUSP7 (designated M1USP7-TUD) largely
reduced the binding afﬁnity to ICP0 and DNMT1 peptides in
GST pull down experiment (Fig. 2A). The above analyses
suggest that TUDUSP7 may recognize consensus primary
sequence containing KxxxK and therefore the acidic pocket
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of TUDUSP7 serves as another binding site (besides the
TRAF) for recognition of USP7-interacting proteins.
To test the hypothesis, we searched human proteins
database and found a number of candidates (including
UHRF1, histone H3, histone H2A) contain such consensus
motif and potentially bind to TUDUSP7 (Fig. 2B). We therefore
used TUDUSP7 and M1USP7-TUD (defective binding to KxxxK
motif) to investigate that whether these proteins bind to
USP7 on the same site. As shown in the GST pull down
assays, wild type TUDUSP7 binds to the KG-Linker of
DNMT1, ICP0 (613–633), UHRF1 (642–674), histone H3 (1–
30), and histone H2A (1–21) (Fig. 2A). We also conﬁrmed
the interaction using the ITC measurement (Fig. 2C). In
contrast, mutation of the residues within the acidic pocket
(M1USP7-TUD) largely decreased the binding afﬁnity to all the
ﬁve peptides (Fig. 2A). In support of this observation, USP7
has been shown to bind to and stabilize UHRF1 and this
interaction is regulated by phosphorylation of UHRF1 during
cell cycle (Ma et al., 2012). However, whether histones H3
and H2A are regulated by USP7 in vivo needs further
investigation.
USP7 is one of the best-characterized deubiquitinases
(Nicholson and Suresh Kumar, 2011). Previous studies have
identiﬁed a number of USP7-binding proteins, including
several substrates for deubiquitination (Sowa et al., 2009).
Mutation W165AUSP7 on the TRAF domain has been shown
to impair its interaction with p53 and MDM2 (Sheng et al.,
2006). We next veriﬁed the interaction between USP7 and its
binding proteins in cells using co-immunoprecipitation to
investigate which site (TRAF or the acidic pocket on
TUDUSP7) on USP7 is responsible for the interaction with
distinct binding proteins. Consistent with above analyses,
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Figure 1. Crystal structure of the USP7-ICP0 complex. (A) Color-coded domain architecture of human USP7 (top) and ribbon
representations of the overall structure of the TUDUSP7-ICP0 complex (bottom). The color scheme is used in all structural ﬁgures. The
ICP0 peptide is colored in forest. The N- and C-termini of USP7 and ICP0 are indicated. (B) Closed-up view of the intermolecular
interaction. USP7 and ICP0 are shown in ribbon representations. Critical residues for the interaction are shown in stick
representation. Hydrogen bonds are shown as dashed lines. (C) GST pull-down assay for the interaction between TUDUSP7 and
ICP0. Wild type and mutants of GST-tagged ICP0 (613–633) were incubated with TUDUSP7 and immobilized on glutathione resin. The
bound proteins were subjected to SDS-PAGE and visualized by Coomassie blue staining. The free GST is resulted from protein
puriﬁcation and would not affect the results. (D) Comparison of TUDUSP7-ICP0 and USP7-DNMT1 structures. In USP7-DNMT1
structure, USP7 is colored in lemon and the KG-Linker in yellow. Critical residues for the interactions are shown in stick
representation. Hydrogen bonds are shown as dashed lines.
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M1USP7-FL abolished its interaction with DNMT1 and ICP0
(Fig. 2D). In contrast, WDR21a, UVSSA, MCMBP, and
MCM4 showed comparable USP7-binding afﬁnity to M1USP7-FL,
but impaired the interaction with W165AUSP7 (Fig. 2D),
indicating that these proteins mainly bind to USP7 on the
TRAF domain. Taken together, USP7 binds to distinct pro-
teins on two separate sites, TRAF and the acidic pocket on
TUDUSP7, respectively.
Intriguingly, WDR21a, UVSSA, MCMBP, MCM4, p53, and
MDM2 (binds to TRAF domain) are involved in cell cycle, DNA
repair or DNA replication, whereas DNMT1 and UHRF1 (binds
to TUDUSP7) are involved in the maintenance of DNA methy-
lation. Thus, our study indicates that the existence of two sub-
strate-binding sties allowsUSP7 to recognize distinct groups of
proteins/substrates for the regulations of different biological
pathways. The proteins that bind to the same substrate-binding
site may compete with each other for regulation if they exist in
the same cellular compartment. Our study also provides a
structural basis for designing inhibitors ofUSP7 that speciﬁcally
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Figure 2. TUD is a new substrate-binding domain. (A) DNMT1, UHRF1, ICP0, histone H3 and H2A bind to the same acidic pocket
of TUDUSP7. The GST pull down assay were performed as in Fig. 1C. (B) The alignment of the corresponding sequences of DNMT1,
UHRF1, ICP0, H3, and H2A. Identical and highly conserved residues are highlighted in dark green and conserved residues in light
green. This indicated that all these protein have the conserved KxxxK motif. (C) ITC measurement of the interactions between
TUDUSP7 and various peptides. (D) The interactions between full-length USP7 and its binding proteins. HEK293T cells were
transiently co-transfected with FLAG-tagged proteins and GFP-tagged USP7 (wild-type and mutants) followed by immunoprecip-
itation. The proteins were detected by immunoblotting using the indicated antibodies.
The second substrates binding domain of USP7 LETTER
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